Coloplast (COLO-B.CO,COLOb.CO) reported that its first half net profit before special items was 2.81 billion Danish kroner, a 6% increase from last year, positively impacted by lower net financial items due to gains on exchange rate adjustments. EBIT before special items was 3.67 billion kroner. EBIT before special items in constant currencies increased 5% compared to last year, while reported EBIT before special items decreased 3% from last year. Group organic growth was 6%, for the period.
Second quarter EBIT before special items was 1.82 billion kroner. EBIT before special items in constant currencies increased 6% compared to last year, while reported EBIT before special items decreased 4% from last year. Group organic growth was 6% in second quarter.
For fiscal 2025/26, Group organic growth is now expected to be 5-6% in constant currencies, from previously around 7%. Reported revenue growth in DKK is now expected at around 3%, from previously around 4%. EBIT growth in constant currencies before special items is now expected at around 5%, from around 7% previously. Return on invested capital after tax before special items is now expected around 15%.
Coloplast revised the financial guidance for fiscal 2025/26, reflecting a slower market recovery in the skin substitutes outpatient setting and a resulting lower growth outlook for Kerecis. Coloplast maintains the long-term financial ambition announced in relation to the launch of Coloplast's 5-year strategy.
At last close, Coloplast shares were trading at 420.30 Danish kroner, down 0.73%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.